Your results for

Filter by

Filter by
Results

Filter by

Content type
Key content topics
Key audience
Top cancer treatments

Short-course hypofractionated proton beam therapy, incorporating 18F-DOPA PET and contrast-enhanced MRI targeting, for patients aged 65 years and older with newly diagnosed glioblastoma: a single-arm phase 2 trial.

27/02/2025
/ Publications

Published in the Lancet Oncology, this study from the Mayo Clinic group reported outcomes of 39 patients with WHO grade 4 glioblastoma treated with concurrent...

Proton beam and carbon ion radiotherapy in skull base chordoma: a systematic review, metaanalysis and meta-regression with trial sequential analysis

27/02/2025
/ Publications

This systematic review and meta-analysis included 14 primary studies comprising 1,145 patients (671 treated with PBT and 474 with CIRT). The only difference...

Intensity-modulated proton therapy versus volumetric-modulated ARC therapy in patients with nasopharyngeal carcinoma: A long-term, multicenter cohort study

27/02/2025
/ Publications

Published in the Green Journal, this study from Taiwan compared treatment results of 276 patients with NPC treated with IMPT with a matched cohort of 276...

Comparing the Oncologic Outcomes of Proton Therapy and Intensity-Modulated Radiation Therapy for Head and Neck Squamous Cell Carcinoma

27/02/2025
/ Publications

Published in the Green Journal, this database study from Taiwan analyzed 982 patients with head and neck squamous cell carcinoma (HNSCC) treated with IMRT or...

Impact of Pre-pectoral Implant Placement and Radiation Modalities (Protons/Photons) in Mastectomy Patients undergoing Immediate Direct-to-Implant Breast Reconstruction.

27/02/2025
/ Publications

Published in the Red Journal, this study from MGH analyzed 392 patients who underwent mastectomy and reconstruction followed by postmastectomy radiotherapy...

Respiratory-gated proton beam therapy for intrahepatic cholangiocarcinoma without fiducial markers.

27/02/2025
/ Publications

This study reported treatment results of 24 patients with ICC treated with respiratory-gated PBT at a dose of 48-83.6 GyRBE in 20-38 fractions. This study...

Role and Effectiveness of Hypofractionated Proton Beam Therapy and Combinations with Systemic Chemotherapy in Inoperable Extrahepatic Cholangiocarcinoma

27/02/2025
/ Publications

This study from the NCC group, Korea, reported the results of 59 patients with inoperable extrahepatic cholangiocarcinoma (EHCC) treated with PBT to a median...

Maximizing your ProteusONE experience

07/10/2021
/ User Meeting

During this event, we will share with you the release program to put in place to...

Five-year outcomes of moderately hypofractionated proton therapy incorporating elective pelvic nodal irradiation for high-risk prostate cancer.

27/02/2025
/ Publications

Published in the Red Journal, this study from the Mayo Clinic reported outcomes of 56 patients with high-risk or unfavorable intermediate-risk treated with...

Proton Radiation Therapy: A Systematic Review of Treatment-Related Side Effects and Toxicities.

27/02/2025
/ Publications

This is a comprehensive review of toxicities associated with proton therapy focusing on the underreported and/or unexpected side effects, with data from 82...